» Articles » PMID: 8064223

Lipopolysaccharide (LPS)-binding Protein is Carried on Lipoproteins and Acts As a Cofactor in the Neutralization of LPS

Overview
Journal J Exp Med
Date 1994 Sep 1
PMID 8064223
Citations 137
Authors
Affiliations
Soon will be listed here.
Abstract

Lipoproteins isolated from normal human plasma can bind and neutralize bacterial lipopolysaccharide (LPS) and may represent an important mechanism in host defense against gram-negative septic shock. Recent studies have shown that experimentally elevating the levels of circulating high-density lipoproteins (HDL) provides protection against death in animal models of endotoxic shock. We sought to define the components of HDL that are required for neutralization of LPS. To accomplish this we have studied the functional neutralization of LPS by native and reconstituted HDL using a rapid assay that measures the CD14-dependent activation of leukocyte integrins on human neutrophils. We report here that reconstituted HDL particles (R-HDL), prepared from purified apolipoprotein A-I (apoA-I) combined with phospholipid and free cholesterol, are not sufficient to neutralize the biologic activity of LPS. However, addition of recombinant LPS binding protein (LBP), a protein known to transfer LPS to CD14 and enhance responses of cells to LPS, enabled prompt binding and neutralization of LPS by R-HDL. Thus, LBP appears capable of transferring LPS not only to CD14 but also to lipoprotein particles. In contrast with R-HDL, apoA-I containing lipoproteins (LpA-I) isolated from plasma by selected affinity immunosorption (SAIS) on an anti-apoA-I column, neutralized LPS without addition of exogenous LBP. Several lines of evidence demonstrated that LBP is a constituent of LpA-I in plasma. Passage of plasma over an anti-apoA-I column removed more than 99% of the LBP detectable by ELISA, whereas 31% of the LBP was recovered by elution of the column. Similarly, the ability of plasma to enable activation of neutrophils by LPS (LBP/Septin activity) was depleted and recovered by the same process. Furthermore, an immobilized anti-LBP monoclonal antibody coprecipitated apoA-I. The results described here suggest that in addition to its ability to transfer LPS to CD14, LBP may also transfer LPS to lipoproteins. Since LBP appears to be physically associated with lipoproteins in plasma, it is positioned to play an important role in the neutralization of LPS.

Citing Articles

Factors Promoting Lipopolysaccharide Uptake by Synthetic Lipid Droplets.

Arnob A, Gairola A, Clayton H, Jayaraman A, Wu H ACS Omega. 2025; 10(6):5866-5873.

PMID: 39989833 PMC: 11840781. DOI: 10.1021/acsomega.4c09599.


A new prognostic model based on serum apolipoprotein AI in patients with HBV-ACLF and acutely decompensated liver cirrhosis.

Mo R, Zhang Z, Zhou Y, Wang Y, Yin P, Zhang C Lipids Health Dis. 2025; 24(1):35.

PMID: 39901194 PMC: 11789380. DOI: 10.1186/s12944-025-02434-8.


High-density lipoprotein cholesterol and nasal colonization of Staphylococcus aureus: results from the 2001-2004 National Health and Nutrition Examination Survey (NHANES).

Wen J, Zhang Z BMC Infect Dis. 2024; 24(1):1235.

PMID: 39497029 PMC: 11533391. DOI: 10.1186/s12879-024-10125-5.


Factors Promoting Lipopolysaccharide Uptake by Synthetic Lipid Droplets.

Arnob A, Gairola A, Clayton H, Jayaraman A, Wu H bioRxiv. 2024; .

PMID: 39464097 PMC: 11507836. DOI: 10.1101/2024.10.19.619182.


What defines a healthy gut microbiome?.

Van Hul M, Cani P, Petitfils C, de Vos W, Tilg H, El-Omar E Gut. 2024; 73(11):1893-1908.

PMID: 39322314 PMC: 11503168. DOI: 10.1136/gutjnl-2024-333378.


References
1.
SKARNES R, Rosen F, Shear M, Landy M . Inactivation of endotoxin by a humoral component. II. Interaction of endotoxin with serum and plasma. J Exp Med. 1958; 108(5):685-99. PMC: 2136910. DOI: 10.1084/jem.108.5.685. View

2.
Tollefson J, Ravnik S, Albers J . Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J Lipid Res. 1988; 29(12):1593-602. View

3.
Rudbach J, Johnson A . RESTORATION OF ENDOTOXIN ACTIVITY FOLLOWING ALTERATION BY PLASMA. Nature. 1964; 202:811-2. DOI: 10.1038/202811a0. View

4.
Weersink A, van Kessel K, van den Tol M, Van Strijp J, Torensma R, Verhoef J . Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein. J Immunol. 1993; 150(1):253-63. View

5.
Kunitake S, Jarvis M, Hamilton R, Kane J . Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. Proc Natl Acad Sci U S A. 1992; 89(15):6993-7. PMC: 49631. DOI: 10.1073/pnas.89.15.6993. View